pura
Menu
Get Pura

Ingredient

Resorcinol

Every other acne active is permitted on its own terms. This one is permitted only in company, and the regulation says so in the same breath as it allows it.

INCI name
Resorcinol
Also on labels as
1,3-Benzenediol, m-Dihydroxybenzene, Resorcinol monoacetate
Found in
cosmetics

Part of Acne-prone skin · Teenage skin

The list of active ingredients a US acne product may use is short enough to read in full, and it is worth reading in full, because one entry on it behaves differently from the rest.

The list

The monograph permits “Benzoyl peroxide, 2.5 to 10 percent”, “Salicylic acid, 0.5 to 2 percent” and “Sulfur, 3 to 10 percent”. Each of those is a complete permission. A product can contain one of them and nothing else and still be a monograph product.

Resorcinol is not written that way. Its entry reads “Resorcinol, 2 percent, when combined with sulfur in accordance with § 333.320(a)”, and the entry below it does the same for the acetate at 3 percent.

The clause is not decoration. It is the permission.

What the condition points at

The combinations section exists to hold exactly two sentences, and both are about the same pairing: “Resorcinol identified in § 333.310(b) may be combined with sulfur identified in § 333.310(f).”

Follow that reference and something else falls out of it. Sulfur on its own is permitted at “Sulfur, 3 to 10 percent”. Paragraph (f), the one resorcinol is sent to, is a different entry: “Sulfur, 3 to 8 percent, when combined with resorcinol or resorcinol monoacetate in accordance with § 333.320.”

So the pairing changes both ingredients. Sulfur’s ceiling drops from 10 percent to 8 when resorcinol joins it, and resorcinol has no permitted existence without it.

What this is worth to someone holding a tube

That is a rare thing to be able to check from a label. Most of what a person can verify on a cosmetic is an order of predominance and a set of names. Here the presence of one name obliges the presence of another, and the obligation is printed in the regulation rather than inferred.

Why it is uncommon now

Resorcinol was a mainstay of the sulfur-and-resorcinol acne preparations that the monograph was written around, and those preparations are still sold. What displaced them was not a safety finding but Benzoyl peroxide, which is permitted at up to 10 percent on its own, and Salicylic acid, which is permitted at up to 2 percent on its own. Neither carries a condition, and a formulator choosing between an ingredient that needs a partner and one that does not will usually choose the one that does not.

The regulation has not changed. The shelf did.

Reading it next to the rest of the shelf

Acne products are among the small number of cosmetics-adjacent items where a concentration has to be printed, because an acne active makes them drugs. The guide to which cosmetic ingredients are actually drugs sets out how far that goes, and how to read a cosmetics label covers what the rest of the list can and cannot tell you.

Sources

  1. 21 CFR 333.310: Acne active ingredients US Food and Drug Administration, via eCFR · ecfr.gov Lists the five permitted acne actives and attaches a combination condition to resorcinol and resorcinol monoacetate alone.
  2. 21 CFR 333.320: Permitted combinations of active ingredients US Food and Drug Administration, via eCFR · ecfr.gov States the only two combinations the acne monograph permits, both of them resorcinol with sulfur.